Insights Into Ph+ ALL and CML 2023

Perspectives on drivers in treatment decisions in the management of philadelphia chromosome-positive (Ph+) acute lymphoblastic Leukemia (ALL) and chronic myeloid leukemia (CML)

March 20, 2023
Purchase Report

Faculty Chair

Elias Jabbour, MD

MD Anderson Cancer Center, Houston, TX, USA

More Information

  • Virtual series

Example Report

Start discovering the insights

View Report

REPORT SNAPSHOT

  • A virtual, moderated roundtable discussion focusing on the treatment of Ph+ ALL and CML
  • Disease state and data presentations are developed in conjunction with a national or regional oncology expert
  • Insights on the following therapies will be obtained
    • Management options in Ph+ ALL
    • Management options in CML
    • Unmet needs and emerging paradigms

GEOGRAPHIC REPRESENTATION & CONTENT DEVELOPMENT

  • Data collection is accomplished through use of audience response system questioning and moderated discussion
  • The group of advisors comprises 10–15 medical oncologists representative of each region

Purchase Report

Thank you for your interest in our insights.

Complete the form below to receive additional information.